Ph2 Open-label Study of AOC 1044 in Duchenne Muscular Dystrophy Participants With Mutations Amenable to Exon44 Skipping
Clinical trial NCT06244082 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06244082
- Sponsor
- Avidity Biosciences, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-22
- Primary completion
- 2027-04-30
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.